日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An Extracellular Matrix-Producing Subset of Cancer-Associated Fibroblasts Drives Chemoresistance in Breast Cancer via SRC Activation and G0S2 Upregulation

癌相关成纤维细胞中产生细胞外基质的亚群通过SRC激活和G0S2上调驱动乳腺癌的化疗耐药性

Hofer, Isabella; Kieffer, Yann; Mencattini, Arianna; Croizer, Hugo; Mhaidly, Rana; Descroix, Stéphanie; Le Tourneau, Christophe; Kamal, Maud; Lamy, Constance; Bonneau, Claire; Cottu, Paul H; Vincent-Salomon, Anne; Martinelli, Eugenio; Mechta-Grigoriou, Fatima; Parrini, Maria Carla

Molecular and cellular composition changes after neoadjuvant letrozole and palbociclib in early luminal breast cancer

早期管腔型乳腺癌新辅助治疗后分子和细胞组成的变化

Cottu, Paul; Kieffer, Yann; Lemonnier, Jerome; D'hondt, Véronique; Duhoux, Francois P; Callens, Céline; Gentien, David; Reyes, Cécile; Boulai, Anais; Desmoulins, Isabelle; Mouret-Reynier, Marie-Ange; Levy, Christelle; Heudel, Pierre-Etienne; Dalenc, Florence; Grenier, Julien; Fuhrmann, Laetitia; Baulande, Sylvain; Delaloge, Suzette; Mechta-Grigoriou, Fatima; Vincent-Salomon, Anne

Real-world effectiveness of palbociclib in combination with an aromatase inhibitor in HR+/HER2- bone-only metastatic breast cancer

帕博西尼联合芳香化酶抑制剂治疗HR+/HER2-骨转移性乳腺癌的真实世界疗效

Brufsky, Adam; Layman, Rachel M; Liu, Xianchen; Li, Benjamin; McRoy, Lynn; Cohen, Aaron B; Estevez, Melissa; Cottu, Paul; Curigliano, Giuseppe; Rugo, Hope S

Real-world progression-free survival 2 (PFS2) and tumor response of CDK4/6 inhibitors plus an aromatase inhibitor in patients with HR+/HER2- metastatic breast cancer in US routine clinical practice

美国常规临床实践中,CDK4/6抑制剂联合芳香化酶抑制剂治疗HR+/HER2-转移性乳腺癌患者的真实世界无进展生存期2(PFS2)和肿瘤反应

Rugo, Hope S; Brufsky, Adam; Layman, Rachel M; Liu, Xianchen; Li, Benjamin; McRoy, Lynn; Cohen, Aaron B; Estevez, Melissa; Lynce, Filipa; Cottu, Paul; Thill, Marc; Curigliano, Giuseppe

Differential benefit of adjuvant everolimus according to endocrine therapy backbone in the randomized UNIRAD trial

在随机UNIRAD试验中,根据内分泌治疗方案的不同,辅助依维莫司治疗的获益存在差异

Saint-Ghislain, M; Chabaud, S; Dalenc, F; Allouache, D; Cameron, D; Martinez, M; Grenier, J; Barthelemy, P; Brunt, M; Kaluzinski, L; Mailliez, A; Legouffe, E; Hardy-Bessard, A-C; Giacchetti, S; Mouret-Reynier, M-A; Canon, J-L; Bliss, J; Lemonnier, J; Andre, F; Bachelot, T; Cottu, P

Causal analyses of the impact of comorbid conditions and concomitant medications on response to neoadjuvant chemotherapy in breast cancer: analysis of a multicenter prospective cohort study (CANTO)

合并症和伴随用药对乳腺癌新辅助化疗疗效影响的因果分析:一项多中心前瞻性队列研究(CANTO)的分析

Hamy, A-S; Grandal, B; Jochum, F; Dumas, É; Sella, N; Kassara, A; Barraud, S; Dubois, T; Ballesta, A; Everhard, S; Lemonnier, J; Sauzey, M; Bertaut, A; Blay, J-Y; Cottu, P; Tredan, O; Joly, F; Gougis, P; Asselain, B; Latouche, A; Vaz Luis, I; Andre, F; Reyal, F

Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trial

在PARSIFAL试验中,对帕博西尼联合氟维司群或来曲唑治疗内分泌敏感、激素受体阳性/HER2阴性晚期乳腺癌患者进行了延长随访。

Llombart-Cussac, A; Pérez-García, J M; Bellet, M; Dalenc, F; Gil-Gil, M; Ruiz-Borrego, M; Gavila, J; Schmid, P; Zamora, P; Wheatley, D; Martínez-de Dueñas, E; Amillano, K; Di Cosimo, S; Anton, A; Cottu, P; Shimizu, E; Fernandez, M; Sampayo-Cordero, M; Cortés, J

Clinico-pathological factors predicting pathological response in early triple-negative breast cancer

预测早期三阴性乳腺癌病理反应的临床病理因素

Helal, Clara; Djerroudi, Lounes; Ramtohul, Toulsie; Laas, Enora; Vincent-Salomon, Anne; Jin, Maxime; Seban, Romain-David; Bieche, Ivan; Bello-Roufai, Diana; Bidard, Francois-Clement; Cottu, Paul; Loirat, Delphine; Carton, Matthieu; Lerebours, Florence; Kiavue, Nicolas; Romano, Emanuela; Bonneau, Claire; Cabel, Luc

Efficacy and toxicity of post-neoadjuvant trastuzumab emtansine in HER2-positive breast cancer patients treated at Institut Curie Hospitals

在居里研究所医院接受治疗的 HER2 阳性乳腺癌患者中,新辅助曲妥珠单抗-美坦新治疗后的疗效和毒性

De Moura, Alexandre; Gleizes, Orane; Cabel, Luc; Bethune-Volters, Anne; Bellesoeur, Audrey; Bello-Roufai, Diana; Cottu, Paul; Sebbag, Clara; Loirat, Delphine; Geiss, Romain; Pierga, Jean-Yves; Escalup, Laurence; Bidard, François Clément; Genevée, Thomas

Attrition between lines of therapy and real-world outcomes of patients with HER2-positive metastatic breast cancer in Europe: a cohort study leveraging electronic medical records

欧洲HER2阳性转移性乳腺癌患者治疗方案间的损耗及真实世界结局:一项利用电子病历的队列研究

Cottu, Paul; Cheeseman, Sue; Hall, Peter; Wöckel, Achim; Scholz, Christian W; Bria, Emilio; Orlandi, Armando; Ribelles, Nuria; Vallet, Mahéva; Niklas, Nicolas; Hogg, Catherine; Aggarwal, Shivani; Moreira, Joana; Lucerna, Markus; Collin, Simon M; Logue, Amanda; Long, Gráinne H